Nuveen, LLC Esperion Therapeutics, Inc. Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
A detailed history of Nuveen, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 422,613 shares of ESPR stock, worth $756,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
422,613
Previous 3,087,700
86.31%
Holding current value
$756,477
Previous $4.45 Million
90.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ESPR
# of Institutions
195Shares Held
121MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$21 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$18.5 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$17.8 Million0.18% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$17.4 Million0.32% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $119M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...